From: Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer
95.0% CI for HR
Group
P-Value
Hazard Ratio
Lower
Upper
Whole Cohort
0.010
2.029
1.185
3.472
No Treatment
0.123
1.866
0.845
4.123
MMC
0.960
1.025
0.392
2.677
BCG
0.023
3.793
1.203
11.956